FABP4 and hyperlipidemia: A-FABP-deficient mice also showed a significant decrease of vascular atherosclerosis in the absence of differences in serum lipids or insulin sensitivity in hyperlipidemia model mice, and this effect was attributed to the action of A-FABP in macrophages[5].